Related Experiment Videos
Neonatal 6-hydroxydopamine treatment affects GABA(A) receptor subunit expression in the frontal cortex but not the
I Podkletnova1, R Mäkelä, E R Korpi
1International Graduate School of Neuroscience, Medical School, University of Tampere, Tampere, Finland.
Insights
Neonatal 6-hydroxydopamine (6-OHDA) treatment transiently delays GABA(A) receptor subunit maturation in the rat prefrontal cortex. This suggests noradrenergic influence is crucial for normal GABAergic interneuron development.
Area of Science:
- Neuroscience
- Developmental Neuroscience
- Neuropharmacology
Background:
- GABA(A) receptors are crucial for inhibitory neurotransmission in the brain.
- Noradrenergic pathways influence brain development and neuronal function.
- The role of neonatal noradrenergic signaling in GABA(A) receptor maturation is not fully understood.
Purpose of the Study:
- To investigate the impact of neonatal 6-hydroxydopamine (6-OHDA) administration on GABA(A) receptor subunit expression and maturation in the rat frontal cortex and hippocampus.
- To determine if noradrenergic depletion affects specific GABA(A) receptor subunits and their developmental timelines.
Main Methods:
- Neonatal rats were treated with 6-OHDA to deplete noradrenergic neurons.
- In situ hybridization was used to quantify mRNA levels of GABA(A) receptor subunits (alpha1, alpha2, alpha5, beta2, beta3, gamma2).
- Immunohistochemistry and autoradiography were employed to assess protein levels and receptor binding.
Main Results:
- Neonatal 6-OHDA treatment selectively and temporarily reduced alpha1 and gamma2 GABA(A) receptor subunit mRNA in the prefrontal cortex.
- This reduction in mRNA correlated with decreased protein levels and altered receptor binding sites.
- No significant changes were observed in the hippocampus or for other GABA(A) receptor subunits.
Conclusions:
- Neonatal noradrenergic depletion transiently delays the maturation of specific GABA(A) receptor subunits in the frontal cortex.
- Despite transient delays, the GABAergic system in the prefrontal cortex may recover, suggesting resilience to early noradrenergic deficits.
Abstract:
The influence of neonatal administration of 6-hydroxydopamine (6-OHDA) on the maturation of GABA(A) receptors in the frontal cortex and hippocampus was studied using 5- to 40-day-old rats. In situ hybridization with antisense oligonucleotide probes was performed for alpha(1), alpha(2), alpha(5), beta(2), beta(3) and gamma(2) subunit mRNAs of the GABA(A) receptor. We demonstrated that neonatal treatment with 6-OHDA temporarily delays the postnatal transcription of the alpha(1) and gamma(2) subunits in the rat prefrontal cortex, as assessed by in situ hybridization histochemistry. The effect was selective for these subunits (the alpha(2), alpha(5), beta(2), and beta(3) subunit mRNAs remained unchanged) and for this region (the mRNA levels in the hippocampus were not changed). The reduction in mRNA levels at early postnatal stages (postnatal day 5, PD5, and PD10) also affected the subunit protein levels, as shown by immunohistochemistry for the alpha(1) subunit, and the formation of GABA(A) receptor-associated picrotoxinin-insensitive TBPS binding sites, as shown by autoradiography. Our findings indicate that without a noradrenergic influence, the maturation of GABAergic interneurons in the frontal cortex is transiently delayed (from PD5 to PD40). However, it is possible that this transient reduction of the expression of certain GABA subunits - caused by depletion of noradrenergic innervation - cannot cause a lasting alteration to the GABAergic function in the prefrontal cortex.